Michael Gormley
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 12
- Cancer Genomics and Diagnostics 11
-
- Prostate Cancer Treatment and Research 29
-
- Epigenetics and DNA Methylation 4
-
- Cancer-related Molecular Pathways 5
- PARP inhibition in cancer therapy 4
- Cancer Immunotherapy and Biomarkers 3
-
- Radiopharmaceutical Chemistry and Applications 15
- Co-authors
- Adam ErtelPaolo FortinaGuillermo M. AlexanderRuby GaoRehman QureshiSeena K. AjitAhmet SaçanYuzhen Tian
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Michael Gormley
44 papers receiving 911 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 380
- Pulmonary and Respiratory Medicine 302
- Molecular Biology 541
- Oncology 166
- Immunology 84
Countries citing papers authored by Michael Gormley
This map shows the geographic impact of Michael Gormley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gormley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gormley more than expected).
Fields of papers citing papers by Michael Gormley
This network shows the impact of papers produced by Michael Gormley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gormley. The network helps show where Michael Gormley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Gormley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 9 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 9 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 36 | |
| 7 | 2019 | 38 | |
| 8 | 2019 | 6 | |
| 9 | 2018 | 40 | |
| 10 | 2018 | 26 | |
| 11 | 2016 | 17 | |
| 12 | 2016 | 56 | |
| 13 | 2015 | 32 | |
| 14 | 2014 | 272 | |
| 15 | 2013 | 35 | |
| 16 | 2013 | 49 | |
| 17 | 2013 | 53 | |
| 18 | 2013 | 21 | |
| 19 | 2011 | 34 | |
| 20 | 2008 | 10 |
About Michael Gormley
Michael Gormley is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 47 papers that have together received 919 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (29 papers), Radiopharmaceutical Chemistry and Applications (15 papers), Cancer, Lipids, and Metabolism (12 papers), Cancer Genomics and Diagnostics (11 papers), Cancer-related Molecular Pathways (5 papers), Epigenetics and DNA Methylation (4 papers), PARP inhibition in cancer therapy (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (380 citations), Pulmonary and Respiratory Medicine (302 citations) and Molecular Biology (541 citations). Michael Gormley has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Adam Ertel, Paolo Fortina, Guillermo M. Alexander, Ruby Gao, Rehman Qureshi, Seena K. Ajit, Ahmet Saçan, Yuzhen Tian, Marguerite K. McDonald and Richard G. Pestell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.